Moogene Medi Co., Ltd. (XKON:322970)

Moogene Medi Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	12.95	100.95	721.41
Revenue Growth (YoY)	-87.17%	-86.01%	-
Cost of Revenue	11.74	6.32	15.12
Gross Profit	1.22	94.63	706.29
Selling, General & Admin	1,253	1,198	1,313
Research & Development	575.89	78.34	35.68
Other Operating Expenses	1.72	14.84	15.81
Operating Expenses	2,063	1,527	1,563
Operating Income	-2,062	-1,433	-856.26
Interest Expense	-26.81	-23.21	-3.95
Interest & Investment Income	6.3	9.34	4.7
Earnings From Equity Investments	-	-	-1
Other Non Operating Income (Expenses)	-1.14	-7.83	-0.13
EBT Excluding Unusual Items	-2,084	-1,454	-856.65
Gain (Loss) on Sale of Assets	-	-19.48	-
Pretax Income	-2,084	-1,474	-856.65
Net Income	-2,084	-1,474	-856.65
Net Income to Common	-2,084	-1,474	-856.65
Shares Outstanding (Basic)	6	2	2
Shares Outstanding (Diluted)	6	2	2
Shares Change (YoY)	201.51%	15.67%	-
EPS (Basic)	-332.00	-708.00	-476.00
EPS (Diluted)	-332.00	-708.00	-476.00
Free Cash Flow	-1,458	-1,755	-760.02
Free Cash Flow Per Share	-232.34	-843.09	-422.31
Gross Margin	9.39%	93.74%	97.90%
Operating Margin	-15919.77%	-1419.23%	-118.69%
Profit Margin	-16086.90%	-1460.03%	-118.75%
Free Cash Flow Margin	-11257.85%	-1738.61%	-105.35%
EBITDA	-1,843	-1,261	-806.65
EBITDA Margin	-	-	-111.81%
D&A For EBITDA	219.49	171.24	49.61
EBIT	-2,062	-1,433	-856.26
EBIT Margin	-	-	-118.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.